Kyron
Entrepreneur First '22Paris, FR · Founded 2022 · 4 known investors
kyron.bio develops protein and antibody therapeutics using a glycan-engineering platform that controls glycosylation patterns. The company operates in the biotech sector and is based in Paris within the Paris Biotech Santé incubator.
BiotechDeep TechHealthtech
Founders & leadership
Kyron was founded in 2022 by Emilia McLaughlin.
EM
Emilia McLaughlininCofounderEmilia McLaughlin received her PhD in cell and molecular biology from Institut Pasteur and has spent more than six years studying evolutionarily diverse organisms. Her work has been supported by several research grants and appears in five publications, two of which list her as first author.
Investors · 4
Frequently asked questions
- What does Kyron do?
- kyron.bio develops protein and antibody therapeutics using a glycan-engineering platform that controls glycosylation patterns. The company operates in the biotech sector and is based in Paris within the Paris Biotech Santé incubator.
- Who founded Kyron?
- Kyron was founded by Emilia McLaughlin in 2022.
- Who are Kyron's investors?
- Kyron's investors include Entrepreneur First, HCVC, SARAS CAPITAL, Verve Ventures.
- Where is Kyron headquartered?
- Kyron is headquartered in Paris, FR.